🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks

RecruitingNAAges any - anyAllHospital Universitari Vall d'Hebron Research Inst…
NCT07500116 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In this project, we aim to validate a Home Hospitalization plan for patients with TIA or minor stroke. Our hypothesis is that our Multimodal Home Hospitalization program (NORAHOME) for patients with TIA and minor stroke is safe, reduces the complications associated with conventional hospitalization, and is more efficient than Standard Clinical Practice. To conduct the study, we require the voluntary participation of patients with TIA and minor strokes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Patients presenting to the Emergency Department with symptoms of TIA (complete recovery of neurological deficits within \<24 hours) or minor stroke (NIHSS ≤ 5) * Age \>18 years. * Availability of a smartphone for the patient or caregiver. * Family support and/or formal caregiver. * Clinical stability during the last 12 hours in the Emergency Department. * Signed informed consent by the patient and/or family member or legal representative. Exclusion Criteria: * Severe stenosis or symptomatic arterial occlusion requiring admission for potential reperfusion and/or arterial revascularization treatments. * Patients with pre-existing neurological or psychiatric conditions that may interfere with or complicate follow-up and evaluations. * Clinical (terminal condition) or social (language barrier) impossibility to complete follow-up assessments.
💊

What it tests

  • Home hospitalization
📍

Where

1 site
Vall Hebron University Hospital
Barcelona, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy